Desmopressin (dDAVP), a synthetic analogue of 8-arginine vasopressin (ADH), is an antidiuretic peptide drug modified by deamination of 1-cysteine and substitution of 8-L-arginine by 8-D-arginine. ADH is an endogenous pituitary hormone that has a crucial role in the control of the water content in the body. Upon release from the stimulation of increased plasm...
1.治疗中枢性尿崩症,可减少尿量、提高尿渗透压、降低血浆渗透压;
2.用于尿崩症的诊断和鉴别诊断;
3.用于治疗夜间遗尿症(六岁或以上的患者);
4.部分类型(甲型血友病和Ⅰ型血管性假血友病)的血友病及其他出血性疾病。
University Hospital Ghent, Ghent, Belgium
University Hospital Ghent, Ghent, Belgium
Avail Clinical Research, LLC, DeLand, Florida, United States
FutureCare Studies, Inc., Springfield, Massachusetts, United States
Urology Center Research Institute, Englewood, New Jersey, United States
Medical Affiliated Research Center Inc., Huntsville, Alabama, United States
Family Medical Center, Foothill Ranch, California, United States
Front Range Clinical Research, Wheatridge, Colorado, United States
National Center for Geriatrics and Gerontology, Obu, Aichi, Japan
Jyusendo General Hospital, Koriyama, Fukushima, Japan
Kawahara Hinyoukika, Kagoshima, Japan
Kansai Medical University Hirakata Hospital, Hirakata, Osaka, Japan
Tamura Children's Clinic, Mito, Ibaraki, Japan
Shinbo Child Clinic, Yokohama, Kanagawa, Japan
Investigational Site - Kurfürstendamm 33, Berlin, Germany
Investigational Site - Marburger Straße 12/13, Berlin, Germany
Investigational Site - Mehrower Allee 22, Berlin, Germany
Asan Medical Center, Seoul, Korea, Republic of
Keimyung University School of Medicine, Daegu, Korea, Republic of
College of Medicine Inha University, Inchon, Korea, Republic of
The University of Hong Kong, Hong Kong, Hong Kong, China
StOlavs Hopital, Trondheim, Norway
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.